5AM Ventures

5AM Ventures

$14,000,000 Venture capital (Series B)
3D Printing Industry , TCT Magazine

LightForce Orthodontics raises $14M in latest round of Series B funding

Pulse 2.0

Viveve Medical Stock (VIVE) Stock: Should I Buy It Now?

$78,000,000 Venture capital (Series A)
Pulse 2.0

Allogeneic Natural Killer Cell Therapy Company Artiva Biotherapeutics Raises $78 Million

Xconomy

Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic

Xconomy

NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation

$55,000,000 Venture capital (Series B)
WSJ Venture Capital

Biotech Startup NodThera to Combat Inflammation With $55 Million Series B

$105,000,000 Venture capital (Series B)
FinSMEs

Akouos Raises $105M in Series B Financing

$105,000,000 Venture capital (Series B)
Pulse 2.0

Precision Genetic Medicine Company Akouos Secures $105 Million In Funding

the home of AI info

Scientist.com and Denovicon Therapeutics Accelerate Medical Research with Complementary AI ...

$33,000,000 Venture capital (Series A)
FinSMEs

Novome Biotechnologies Secures $33M in Series A Financing

the home of AI info

Pear Therapeutics Expands Pipeline with Machine Learning, Digital Therapeutic and Digital ...

$25,000,000 Venture capital (Series B)
AlleyWatch

TMRW Life Sciences Raises $25M for its Cryo-management Platform to Safeguard Life’s Most Precious Cells

$22,000,000 Venture capital (Series F)
Pulse 2.0

RareCyte Closes $22 Million In Funding

FinSMEs

RareCyte Raises $22M Financing Round

Pulse 2.0

Automated Embryology And Cryo-Management Company TMRW Raises $25 Million

FinSMEs

TMRW Life Sciences Closes $25M Series B Funding

the home of AI info

scPharmaceuticals Inc. (SCPH) and Minerva Neurosciences Inc. (NASDAQ:NERV) Comparing ...

Technical.ly Philly

University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO

PE HUB

VC-backed Cabaletta Bio begins trading on NASDAQ

the home of AI info

Is The Stock Worthy? Viveve Medical, Inc. (NASDAQ:VIVE), Minerva Neurosciences, Inc. (NASDAQ ...